Molbank (Jul 2023)

Synthesis, Crystal Structure and Anti-Leukemic Activity of (<i>E</i>)-Pyrrolo[1,2-<i>a</i>]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

  • Jean Guillon,
  • Solène Savrimoutou,
  • Sandra Albenque-Rubio,
  • Noël Pinaud,
  • Nina Fillová,
  • Stéphane Moreau,
  • Virginie Baylot,
  • Vanessa Desplat

DOI
https://doi.org/10.3390/M1691
Journal volume & issue
Vol. 2023, no. 3
p. M1691

Abstract

Read online

(E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one was designed then synthesized using a multi-step pathway starting from commercially available 2-nitroaniline. Structure characterization of this original substituted pyrrolo[1,2-a]quinoxaline compound was achieved by using FT-IR, 1H-NMR, 13C-NMR, X-Ray and HRMS spectral analysis. This new pyrroloquinoxaline shows interesting cytotoxic potential against different human leukemia cell lines (MV4-11, K562, MOLM14 and Jurkat cells).

Keywords